Apolipoprotein E4 in Alzheimer's Disease: Role in Pathology, Lipid Metabolism, and Drug Treatment.

Int J Mol Sci · 2026 · PMC12842209 · PMID 41596649

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

also noted a possible trend toward greater cognitive response in ApoE4 carriers with longer treatment durations (>9 months), though this did not show statistical significance [ 121 ].

also in 939 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.